NCT07699965

Brief Summary

The goal of this observational study is to lean that whether the distinct mechanisms by which intravascular lithotripsy (IVL) and rotational atherectomy (RA) treat severe coronary calcification differentially affect the microcirculation, leading to coronary microvascular dysfunction (CMD). The main question it aims to answer is: we evaluated the prognostic value of post-percutaneous coronary intervention (PCI) CMD, assessed by the angiography-derived index of microcirculatory resistance (angio-IMR), in patients with severe coronary calcification undergoing RA or IVL. Participants will answer survey questions about their clinical outcomes for 1 year by telephone

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
590

participants targeted

Target at P75+ for all trials

Timeline
1mo left

Started Jan 2018

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress98%
Jan 2018Sep 2026

Study Start

First participant enrolled

January 1, 2018

Completed
7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

July 7, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 13, 2026

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2026

Expected
Last Updated

July 13, 2026

Status Verified

June 1, 2026

Enrollment Period

7 years

First QC Date

July 7, 2026

Last Update Submit

July 7, 2026

Conditions

Keywords

Intravascular lithotripsyRotational atherectomyCoronary microcirculation dysfunctionCoronary artery calcificationIndex of microcirculatory resistance

Outcome Measures

Primary Outcomes (1)

  • MACE

    composite of cardiac death, myocardial infarction, target vessel revascularization, or readmission for unstable angina

    1 year

Secondary Outcomes (1)

  • target vessel failure

    1 year

Study Arms (2)

Intravascular lithotripsy group

Angio-IMR\>=25 OR Angio-IMR\<25

Rotational atherectomy

Angio-IMR\>=25 OR Angio-IMR \<25

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Consecutive patients who underwent RA or IVL due to serve calcification during the PCI between January 1, 2018, and October 31, 2024.

You may qualify if:

  • Consecutive patients who underwent RA or IVL due to serve calcification during the PCI. Severe calcification was defined angiographically as radiopacities visible on both sides of the vessel lumen before contrast injection, or by intravascular ultrasound (IVUS) as a circumferential arc of calcification ≥270° extending for ≥5 mm in length-

You may not qualify if:

  • encompassed the presence of severe calcification treated with RA and IVL, in-stent restenosis and suboptimal angiographic image quality

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Second Affiliated Hospital of Zhejiang University School of Medicine 88 Jiefang Road

Hangzhou, Zhejiang, 310009, China

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 7, 2026

First Posted

July 13, 2026

Study Start

January 1, 2018

Primary Completion

December 31, 2024

Study Completion (Estimated)

September 30, 2026

Last Updated

July 13, 2026

Record last verified: 2026-06

Locations